Guest guest Posted June 21, 2012 Report Share Posted June 21, 2012 Conclusions: These pilot data suggest reasonable safety, tolerability and efficacy of armodafinil therapy in hypersomnolent DLB subjects. http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/P04.\ 192 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.